Xiaoying He

1.1k total citations
43 papers, 782 citations indexed

About

Xiaoying He is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Xiaoying He has authored 43 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Xiaoying He's work include Renal Transplantation Outcomes and Treatments (4 papers), Renal Diseases and Glomerulopathies (3 papers) and Cancer therapeutics and mechanisms (3 papers). Xiaoying He is often cited by papers focused on Renal Transplantation Outcomes and Treatments (4 papers), Renal Diseases and Glomerulopathies (3 papers) and Cancer therapeutics and mechanisms (3 papers). Xiaoying He collaborates with scholars based in China, United States and Denmark. Xiaoying He's co-authors include Jeffrey G. Supko, Pan Huang, Sergej Konoplev, Vikas P. Sukhatme, Geoffrey I. Shapiro, Donald P. Lawrence, Colin J. Meyer, Donald Küfe, James W. Mier and Hillard Lazarus and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Clinical Cancer Research and Endocrinology.

In The Last Decade

Xiaoying He

43 papers receiving 754 citations

Peers

Countries citing papers authored by Xiaoying He

Since Specialization

Citations

This map shows the geographic impact of Xiaoying He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoying He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoying He more than expected).

Fields of papers citing papers by Xiaoying He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoying He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoying He. The network helps show where Xiaoying He may publish in the future.

Co-authorship network of co-authors of Xiaoying He

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoying He. A scholar is included among the top collaborators of Xiaoying He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoying He. Xiaoying He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hypothesis: Platelet-rich plasma accelerate diabetic wound healing via dynamic modulation of multiple signaling pathways 2023 ·Medical Hypotheses ·Ju Tian, Xiaoying He, (unknown), (unknown)	7
2	Platelet concentrates may affect the formation of pathological scars by regulating epithelial to mesenchymal transition 2023 ·Medical Hypotheses ·Ju Tian, (unknown), (unknown), (unknown), Huimin You, Xiaoying He, Biao Cheng	1
3	P38 MAPK, NF-κB, and JAK-STAT3 Signaling Pathways Involved in Capecitabine-Induced Hand-Foot Syndrome via Interleukin 6 or Interleukin 8 Abnormal Expression 2022 ·Chemical Research in Toxicology ·Xiaoying He, Jiali Wang, Qian Wang, Jing Liu, Xi Yang, Lingjuan He, Haihong Hu, Su Zeng, Lushan Yu, Yunqing Qiu, Yan Lou	8
4	miR-1275 Inhibits Human Omental Adipose-Derived Stem Cells Differentiation Toward the Beige Phenotype via PRDM16 2022 ·Stem Cells and Development ·Chenhong Lin, Xiaoying He, Xueying Chen, Liehua Liu, Hongyu Guan, (unknown), Yanbing Li	2
5	Plasma metabolites, especially lipid metabolites, are altered in pregnant women with gestational diabetes mellitus 2021 ·Clinica Chimica Acta ·(unknown), (unknown), Xiaoying He, Mingzhu Huang, Xi Yang, Lingjuan He, Yunqing Qiu, (unknown)	23
6	The Value of Combined Detection of D‐dimer and CD62p in Judging the Severity of Acute Cerebral Infarction and Short‐Term Prognosis 2021 ·BioMed Research International ·Min Xu, Xiaoying He, Pan Huang	6
7	Population pharmacokinetics and individual analysis of daptomycin in kidney transplant recipients 2021 ·European Journal of Pharmaceutical Sciences ·Yan Lou, (unknown), Jiali Wang, (unknown), Lingjuan He, Xi Yang, Haoxiang Xu, Xiaoying He, (unknown), Chunchun Wei, Hongfeng Huang	3
8	Polycystic ovary syndrome is an independent risk factor for hypertensive disorders of pregnancy: A systematic review, meta-analysis, and meta-regression 2021 ·Endocrine ·Haixia Pan, (unknown), Daopeng Yang, (unknown), (unknown), Xiaoying He, (unknown), Xiaohui Wen, Hongxia Ma, Maohua Lai	15
9	Elevation of Serum Cytokine Profiles and Liver Metabolomic Normalization in Early Convalescence of COVID-19 Patients 2021 ·Frontiers in Medicine ·Yan Lou, Xiaoying He, (unknown), Xingjiang Hu, (unknown), Lin Liu, (unknown), Lingjuan He, Jiali Wang, Li Zhang, Qingwei Zhao, Xiaoyang Lu, Yunqing Qiu	6
10	Novel Roles of Chloroquine and Hydroxychloroquine in Graves’ Orbitopathy Therapy by Targeting Orbital Fibroblasts 2020 ·The Journal of Clinical Endocrinology & Metabolism ·Yan Guo, Hai Li, Xueying Chen, Huasheng Yang, Hongyu Guan, Xiaoying He, (unknown), Sunil Pokharel, Haipeng Xiao, Yanbing Li	16
11	Multiple low doses of erythropoietin delay the proliferation of hepatocytes but promote liver function in a rat model of subtotal hepatectomy 2014 ·Surgery Today ·(unknown), Xianhua Xu, Ru Zhang, Xiaoying He, (unknown), (unknown), (unknown), (unknown)	5
12	A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas 2012 ·Clinical Cancer Research ·David S. Hong, Razelle Kurzrock, Jeffrey G. Supko, Xiaoying He, Aung Naing, Jennifer J. Wheler, Donald P. Lawrence, Joseph P. Eder, Colin J. Meyer, Deborah A. Ferguson, James W. Mier, Marina Konopleva, Sergej Konoplev, Michael Andreeff, Donald Küfe, Hillard Lazarus, Geoffrey I. Shapiro, Bruce J. Dezube	197
13	Ipr1 Gene Mediates RAW 264.7 Macrophage Cell Line Resistance to Mycobacterium bovis 2011 ·Scandinavian Journal of Immunology ·Xianbao He, Feng Su, (unknown), (unknown), Yongli Song, H. Y. Chang, (unknown), Jie Lan, Xiaoying He, Yong Zhang	9
14	C-Terminal Peptide of Anaphylatoxin C3a Enhances Hepatic Function After Steatotic Liver Transplantation: A Study in a Rat Model 2010 ·Transplantation Proceedings ·(unknown), (unknown), (unknown), Hu Meng, (unknown), (unknown), Xiaoying He, Xianchao Xiao	2
15	[A survey of glucose and lipid metabolism and concomitant diseases among inpatients in Guangdong province]. 2009 ·PubMed ·Kuanxiao Tang, (unknown), (unknown), Yaoming Xue, Hua-zhang Yang, Lu Li, De-hong Cai, (unknown), Fan Zhang, Longyi Zeng, Shaoda Lin, (unknown), Xuan Xia, Xiaoying He, Fen Xu, Jianping Weng	1
16	Identification of the in Vitro Metabolites of 3,4-Dihydro-2,2-dimethyl-2H-naphthol[1,2-b ]pyran-5,6-dione (ARQ 501; β-Lapachone) in Whole Blood 2008 ·Drug Metabolism and Disposition ·Xiu‐Sheng Miao, (unknown), Ronald E. Savage, Caiyun Zhong, Rui‐Yang Yang, Darin Kizer, Hui Wu, Erika Volckova, Mark A. Ashwell, Jeffrey G. Supko, Xiaoying He, Thomas Chan	25
17	Prolonged stabilization of platinum-resistant ovarian cancer in a single patient consuming a fermented soy therapy 2005 ·Gynecologic Oncology ·(unknown), Xiaoying He, Maria Roche, (unknown), (unknown), Jeffrey G. Supko, Michael V. Seiden	16
18	Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 administered as a weekly 24 h continuous intravenous infusion in patients with advanced solid tumors 2005 ·Cancer Chemotherapy and Pharmacology ·Joseph P. Eder, David P. Ryan, Leonard J. Appleman, Andrew X. Zhu, Thomas A. Puchalski, Xiaoying He, Daryl Sonnichsen, Michael R. Cooper, James R. Wright, Jeffrey W. Clark, Jeffrey G. Supko	3
19	Increased endothelial uptake of paclitaxel as a potential mechanism for its antiangiogenic effects: Potentiation by Cox‐2 inhibition 2004 ·International Journal of Cancer ·Jaime R. Merchan, (unknown), Jeffrey G. Supko, Xiaoying He, Glenn J. Bubley, Vikas P. Sukhatme	66
20	Determination of procarbazine in human plasma by liquid chromatography with electrospray ionization mass spectrometry 2003 ·Journal of Chromatography B ·Xiaoying He, (unknown), Stuart A. Grossman, Jeffrey G. Supko, (unknown)	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact